2024 Diagnose Disease Nuclear Medicine 
Imaging Technology
JUNE 12, 2024
Integrating AI with our advanced imaging techniques will allow us to detect subtle changes in brain activity indicative of neurodegenerative diseases at their nascent stage. More information: www.SimonMed.com Wednesday, June 12, 2024 - 11:45
Imaging Technology
JUNE 11, 2024
milla1cf Tue, 06/11/2024 - 18:41 June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the “Alzheimer’s disease of the heart.” About 20 percent of patients who have amyloid build-up in the heart experience early deaths.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JULY 10, 2024
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosing disease as part of the packaged cost of imaging procedures in hospital outpatient settings. Mo-99 is the source material for Tc-99m, which is used in an estimated 40,000 nuclear medicine diagnostic exams each day in the U.S.
AuntMinnie
JUNE 8, 2024
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI).
AuntMinnie
JUNE 10, 2024
GE HealthCare introduced the MINItrace Magni at the Society of Nuclear Medicine and Molecular Imaging annual meeting (SNMMI) annual meeting, a newly designed, small-footprint cyclotron for in-house production of commercial PET radiotracers. The system’s 21 cm digital detector offers a 1.6-times
AuntMinnie
JUNE 8, 2024
TORONTO -- AuntMinnie.com spoke with cardiac PET imaging expert Krishna Patel, MD, from Mount Sinai in New York City, at the Society of Nuclear Medicine and Molecular Imaging annual meeting. Women are 2.5 to three times more likely to suffer from INOCA and coronary artery microvascular disfunction than men.
AuntMinnie
MARCH 26, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.
Expert insights. Personalized for you.
115 
Let's personalize your content